Cansortium (XCNQ:TIUM.U) 3-Year Revenue Growth Rate : 11.70% (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Cansortium 3-Year Revenue Growth Rate?

Cansortium's Revenue per Share for the three months ended in Dec. 2023 was $0.07.

During the past 12 months, Cansortium's average Revenue per Share Growth Rate was -1.80% per year. During the past 3 years, the average Revenue per Share Growth Rate was 11.70% per year. During the past 5 years, the average Revenue per Share Growth Rate was 23.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 6 years, the highest 3-Year average Revenue per Share Growth Rate of Cansortium was 30.50% per year. The lowest was 11.70% per year. And the median was 30.40% per year.

Competitive Comparison of Cansortium's 3-Year Revenue Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Cansortium's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cansortium's 3-Year Revenue Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cansortium's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Cansortium's 3-Year Revenue Growth Rate falls into.

Cansortium 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Cansortium (XCNQ:TIUM.U) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Cansortium 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Cansortium's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Cansortium (XCNQ:TIUM.U) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cansortium Inc (XCNQ:TIUM.U) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

CNTMF:USA

Address

82 North East 26th Street, Suite 110, Miami, FL, USA, 33137

Website

https://getfluent.com

Cansortium Inc is licensed to produce and sell medical cannabis in Florida and Texas and is licensed to sell medical cannabis in Pennsylvania. Its medical cannabis products are offered in oral drops, capsules, topicals, syringes, dried flowers, pre-rolls, cartridges, and edibles. All of the company's products are marketed under the Fluent brand name. In Pennsylvania, the company's product portfolio is comprised of a variety of third-party branded medical cannabis products.

Cansortium (XCNQ:TIUM.U) Headlines

No Headlines